3-38566576-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_001099404.2(SCN5A):c.3673G>A(p.Glu1225Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1225Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_001099404.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.3673G>A | p.Glu1225Lys | missense_variant | 21/28 | ENST00000413689.6 | |
SCN5A | NM_000335.5 | c.3670G>A | p.Glu1224Lys | missense_variant | 21/28 | ENST00000423572.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.3673G>A | p.Glu1225Lys | missense_variant | 21/28 | 5 | NM_001099404.2 | P4 | |
SCN5A | ENST00000423572.7 | c.3670G>A | p.Glu1224Lys | missense_variant | 21/28 | 1 | NM_000335.5 | A1 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249528Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135354
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461388Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726984
GnomAD4 genome ? Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 05, 2024 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1225 of the SCN5A protein (p.Glu1225Lys). This variant is present in population databases (rs199473204, gnomAD no frequency). This missense change has been observed in individuals with Brugada syndrome (PMID: 22840528, 23321620, 24136861, 28341781, 28781330, 29574140, 30193851, 31737537). ClinVar contains an entry for this variant (Variation ID: 67810). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (PMID: 32533946) did not meet the statistical confidence thresholds required to predict the impact of this variant on SCN5A function. Experimental studies have shown that this missense change affects SCN5A function (PMID: 34219138). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 22, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 03, 2023 | Reported previously in multiple individuals with definitive or suspected Brugada syndrome (Smits et al., 2002; Schulze-Bahr et al., 2003; Kapplinger et al., 2010; Crotti et al., 2012) or LQTS (Tester et al., 2005); Published functional studies suggest the variant results in loss of protein function (Ishikawa et al., 2021); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24136861, 15840476, 20129283, 34461752, 19606473, 23424222, 22840528, 22581653, 28341781, 32533946, 31737537, 34219138, 33131149, 30662450, 33221895, 29574140, 30193851, 12106943, 14961552, 30203441, 23321620, 28781330, 33164571, 36516610, 37061847) - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The p.E1225K variant (also known as c.3673G>A), located in coding exon 20 of the SCN5A gene, results from a G to A substitution at nucleotide position 3673. The glutamic acid at codon 1225 is replaced by lysine, an amino acid with similar properties. This variant has been reported in individuals with Brugada syndrome (Smits JP et al. J Am Coll Cardiol, 2002 Jul;40:350-6; Crotti L et al. J Am Coll Cardiol, 2012 Oct;60:1410-8; Sommariva E et al. Eur J Hum Genet, 2013 Sep;21:911-7; Van Malderen SCH et al. Circ J, 2017 Dec;82:53-61; Sonoda K et al. Heart Rhythm, 2018 Aug;15:1179-1188). In vitro studies showed this alteration reduces peak current density (Glazer AM et al. Am J Hum Genet, 2020 Jul;107:111-123; Ishikawa T et al. Eur Heart J, 2021 Jul;42:2854-2863; Salvarani N et al. Int J Mol Sci, 2023 May;24:[ePub ahead of print]). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Cardiac arrhythmia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Nov 16, 2022 | This missense variant replaces glutamic acid with lysine at codon 1225 in the transmembrane domain DIII of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). An electrophysiological functional study has shown that this variant results in partial loss of sodium channel function (PMID: 34219138). This variant has been reported in over ten individuals affected with Brugada syndrome (PMID: 22840528, 23321620, 24136861, 28341781, 28781330, 29574140, 30193851, 31737537, 34219138). This variant has been identified in 1/249528 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Brugada syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jan 01, 2019 | - - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at